Basic Information
ID: ALA2020773
Type: Binding
Description: Inhibition of human recombinant CK2 (alphaalpha-betabeta) holoenzyme using RRRDDDSDDD as substrate and 15 uM ATP by radiometric assay
Format: BAO_0000223
Organism: Homo sapiens
Target: Casein kinase II alpha/beta(ALA3038477)
Document: ALA2016532
Inhibition of human recombinant CK2 (alphaalpha-betabeta) holoenzyme using RRRDDDSDDD as substrate and 15 uM ATP by radiometric assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA2020773
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 343.42 | 4.98 | 4.98 |
| 377.86 | 5.63 | 5.63 |
| 361.41 | 5.12 | 5.12 |
| 343.42 | 4.98 | 4.98 |
| 377.86 | 5.63 | 5.63 |
| 343.42 | 4.98 | 4.98 |
| 377.86 | 5.63 | 5.63 |
| 378.85 | 5.03 | 5.03 |
| 326.36 | 4.02 | 4.02 |
| 360.81 | 4.67 | 4.67 |
| 344.35 | 4.16 | 4.16 |
| 345.34 | 3.55 | 3.55 |
| 307.38 | 3.81 | 3.81 |
| 337.41 | 3.07 | 3.07 |
| 357.44 | 4.85 | 4.85 |
| 344.40 | 4.37 | 4.37 |
| 344.40 | 4.37 | 4.37 |
| 377.86 | 5.63 | 5.63 |
| 377.86 | 5.63 | 5.63 |
| 393.86 | 5.34 | 5.34 |
| 395.85 | 5.77 | 5.77 |
| 407.89 | 5.64 | 5.64 |
| 379.40 | 5.26 | 5.26 |
| 461.86 | 6.53 | 6.53 |
| 361.41 | 5.12 | 5.12 |
| 361.41 | 5.12 | 5.12 |
| 379.40 | 5.26 | 5.26 |
| 379.40 | 5.26 | 5.26 |
| 373.44 | 4.99 | 4.99 |
| 373.44 | 4.99 | 4.99 |
| 373.44 | 4.99 | 4.99 |
| 430.54 | 4.92 | 4.92 |
| 411.41 | 6.00 | 6.00 |
| 368.43 | 4.85 | 4.85 |
| 367.44 | 4.96 | 4.96 |
| 386.44 | 4.08 | 4.08 |
| 354.82 | 5.54 | 5.54 |
| 353.83 | 4.95 | 4.95 |
| 367.86 | 5.21 | 5.21 |
| 375.43 | 5.43 | 5.43 |